Showing results (1-10 of 922) with videos related to
Sort By:
Pageof 93
European Journal of Pharmacology|March 4, 1983
Partial purification of [3H]mianserin binding sitesB Chan, B K MadrasEuropean Journal of Pharmacology|September 10, 1982
[3H]Mianserin binding to solubilized membranes of frontal cortexB Chan, B K MadrasEuropean Journal of Pharmacology|June 16, 1982
Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptorsB Chan, P Seeman, A Davis, et al.European Journal of Pharmacology|August 27, 1981
Assay for soluble dopamine receptors by the precipitation methodB Chan, B K Madras, A Davis, et al.The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeysM Goulet, B K MadrasMolecular Psychiatry|October 17, 1998
Anti-hyperactivity medication: methylphenidate and amphetamineP Seeman, B K MadrasHandbook of Experimental Pharmacology|May 26, 2006
Human genetics and pharmacology of neurotransmitter transportersZ Lin, B K MadrasJournal of Neurochemistry|March 1, 1985
Drug potencies on partially purified brain D2 dopamine receptorsB K Madras, P SeemanMolecular Psychiatry|January 23, 2002
Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expressionG M Miller, B K MadrasSynapse (New York, N.Y.)|September 1, 1991
Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatumM J Kaufman, B K MadrasPageof 93